Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Arch Pediatr
1 Arch Virol
11 Clin Infect Dis
5 J Infect Dis
1 J Pediatr
1 J Virol
7 Lancet
3 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
2 Nat Med
4 PLoS One
1 Proc Natl Acad Sci U S A
1 Science
25 Vaccine
1 Virus Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


  1. RUDDY JA, Boyarsky BJ, Werbel WA, Bailey JR, et al
    Safety and antibody response to the first dose of SARS-CoV-2 messenger RNA vaccine in persons with HIV.
    AIDS. 2021 May 14. pii: 00002030-900000000-96405.
    PubMed         Abstract available

    Arch Pediatr

  2. MENUEY A, Cohen R, Bechet S, Levy C, et al
    Infovac-France survey in pediatric vaccinology: How does it compare with the literature?
    Arch Pediatr. 2021 May 13. pii: S0929-693X(21)00088.
    PubMed         Abstract available

    Arch Virol

  3. GAO Y, Li P, Ma X, Bai X, et al
    The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus.
    Arch Virol. 2021 May 18. pii: 10.1007/s00705-021-05100.
    PubMed         Abstract available


  4. GONSALVES G, Yamey G
    The covid-19 vaccine patent waiver: a crucial step towards a "people's vaccine".
    BMJ. 2021;373:n1249.

  5. WISE J
    Covid-19: Second vaccine doses expedited in areas of England where new variant is high.
    BMJ. 2021;373:n1266.

    Covid-19: Most UK adults had antibodies after one dose of AstraZeneca or Pfizer vaccine, data suggest.
    BMJ. 2021;373:n1274.

  7. DOSHI P
    Covid-19 vaccines: In the rush for regulatory approval, do we need more data?
    BMJ. 2021;373:n1244.

    Covid-19: Advocates urge India's prime minister to remove barriers to vaccine production and access.
    BMJ. 2021;373:n1297.

  9. RAZAI MS, Chaudhry UAR, Doerholt K, Bauld L, et al
    Covid-19 vaccination hesitancy.
    BMJ. 2021;373:n1138.

    Clin Infect Dis

  10. SALAMA M, Indenbaum V, Nuss N, Savion M, et al
    A Measles Outbreak in the Tel Aviv District, Israel, 2018-2019.
    Clin Infect Dis. 2021;72:1649-1656.
    PubMed         Abstract available

  11. GIBNEY KB, MacLachlan J, Coutts R, Higgins N, et al
    Incidence of invasive pneumococcal disease higher among people notified with markers of hepatitis C virus infection: Population-based surveillance in Victoria, Australia 2001-2017.
    Clin Infect Dis. 2020 Aug 4. pii: 5880584. doi: 10.1093/cid/ciaa1110.
    PubMed         Abstract available

  12. BENET T, Amour S, Valette M, Saadatian-Elahi M, et al
    Incidence of Asymptomatic and Symptomatic Influenza Among Healthcare Workers: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2021;72:e311-e318.
    PubMed         Abstract available

  13. COHEN R, Levy C, Ouldali N, Goldrey M, et al
    Invasive Disease Potential of Pneumococcal Serotypes in Children After PCV13 Implementation.
    Clin Infect Dis. 2021;72:1453-1456.
    PubMed         Abstract available

  14. CANADAY DH, Carias L, Oyebanji OA, Keresztesy D, et al
    Reduced BNT162b2 mRNA vaccine response in SARS-CoV-2-naive nursing home residents.
    Clin Infect Dis. 2021 May 16. pii: 6276391. doi: 10.1093.
    PubMed         Abstract available

  15. BAILLY B, Guilpain L, Bouiller K, Chirouze C, et al
    BNT162b2 mRNA vaccination did not prevent an outbreak of SARS COV-2 variant 501Y.V2 in an elderly nursing home but reduced transmission and disease severity.
    Clin Infect Dis. 2021 May 16. pii: 6276392. doi: 10.1093.
    PubMed         Abstract available

  16. CHODICK G, Tene L, Rotem RS, Patalon T, et al
    The effectiveness of the TWO-DOSE BNT162b2 vaccine: analysis of real-world data.
    Clin Infect Dis. 2021 May 17. pii: 6276888. doi: 10.1093.
    PubMed         Abstract available

  17. ROYER G, Clermont O, Condamine B, Mercier-Darty M, et al
    O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
    Clin Infect Dis. 2021 May 17. pii: 6277090. doi: 10.1093.

  18. DANINO D, Van Der Beek BA, Givon-Lavi N, Greenberg D, et al
    Unravelling the Impact of Pneumococcal Conjugate Vaccines on Ambulatory Antibiotic Drug Consumption in Young Children: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2021 May 20. pii: 6278471. doi: 10.1093.
    PubMed         Abstract available

  19. GRIJALVA CG, Feldstein LR, Talbot HK, Aboodi M, et al
    Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness among Adults in the United States, 2019-2020: A test-negative study.
    Clin Infect Dis. 2021 May 20. pii: 6279050. doi: 10.1093.
    PubMed         Abstract available

  20. OGATA AF, Cheng CA, Desjardins M, Senussi Y, et al
    Circulating SARS-CoV-2 Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
    Clin Infect Dis. 2021 May 20. pii: 6279075. doi: 10.1093.
    PubMed         Abstract available

    J Infect Dis

  21. COREY L
    Behind the Scenes Heroes: the COVID-19 Vaccine Data and Safety Monitoring Board.
    J Infect Dis. 2021 May 19. pii: 6278073. doi: 10.1093.

  22. BIANCHI FP, Germinario CA, Migliore G, Vimercati L, et al
    BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report.
    J Infect Dis. 2021 May 19. pii: 6278131. doi: 10.1093.
    PubMed         Abstract available

  23. JOFFE S, Babiker A, Ellenberg SS, Fix A, et al
    Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
    J Infect Dis. 2021 May 19. pii: 6278127. doi: 10.1093.
    PubMed         Abstract available

  24. FELDSTEIN LR, Ferdinands JM, Self WH, Randolph AG, et al
    Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates.
    J Infect Dis. 2021 May 20. pii: 6278475. doi: 10.1093.
    PubMed         Abstract available

  25. MAHON BE, Simon J, Widdowson MA, Samai M, et al
    Baseline Asymptomatic Malaria Infection and Immunogenicity of rVSVDeltaG-ZEBOV-GP Vaccine: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).
    J Infect Dis. 2021 May 20. pii: 6278485. doi: 10.1093.
    PubMed         Abstract available

    J Pediatr

  26. HAYES EA, Hart SA, Gowda C, Nandi D, et al
    Hospitalizations for Respiratory Syncytial Virus and Vaccine Preventable Infections following Pediatric Heart Transplantation.
    J Pediatr. 2021 May 14. pii: S0022-3476(21)00448.
    PubMed         Abstract available

    J Virol

  27. AO Z, Wang L, Azizi H, Abiola TO, et al
    Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New DC-Targeting Vaccine Approach Against HIV-1.
    J Virol. 2021 May 19. pii: JVI.02368-20. doi: 10.1128/JVI.02368.
    PubMed         Abstract available


    New Guideline Calls for Cervical Cancer Screening to Begin at Age 25 Years.
    JAMA. 2020 Nov 6. pii: 2772859. doi: 10.1001/jama.2020.21706.


  29. GOSTIN LO, Shalala DE, Hamburg MA, Bloom BR, et al
    A global health action agenda for the Biden administration.
    Lancet. 2021;397:5-8.

  30. HOLT E
    Serbia begins paying citizens to receive a COVID-19 vaccine.
    Lancet. 2021;397:1793.

  31. HOUSTON AR, Murthy S
    Canada is no global health leader on COVID-19 vaccine equity.
    Lancet. 2021;397:1803.

  32. TORRES I, Lopez-Cevallos D, Artaza O, Profeta B, et al
    Vaccine scarcity in LMICs is a failure of global solidarity and multilateral instruments.
    Lancet. 2021;397:1804.

    Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
    Lancet. 2021;397:1804-1805.

  34. LOYO ESL, Gonzalez MJ, Esparza J
    Venezuela is collapsing without COVID-19 vaccines.
    Lancet. 2021;397:1806.

  35. JHA P, Jamison DT, Watkins DA, Bell J, et al
    A global compact to counter vaccine nationalism.
    Lancet. 2021 May 14. pii: S0140-6736(21)01105.

    MMWR Morb Mortal Wkly Rep

  36. WALLACE M, Woodworth KR, Gargano JW, Scobie HM, et al
    The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years - United States, May 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:749-752.
    PubMed         Abstract available

  37. MURTHY BP, Sterrett N, Weller D, Zell E, et al
    Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties - United States, December 14, 2020-April 10, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:759-764.
    PubMed         Abstract available

  38. PILISHVILI T, Fleming-Dutra KE, Farrar JL, Gierke R, et al
    Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel - 33 U.S. Sites, January-March 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:753-758.
    PubMed         Abstract available

    N Engl J Med

    Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMe2103931.

  40. WHITE EM, Yang X, Blackman C, Feifer RA, et al
    Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2104849.

  41. VAYNE C, Rollin J, Gruel Y, Pouplard C, et al
    PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia.
    N Engl J Med. 2021 May 19. doi: 10.1056/NEJMc2106383.

  42. RUBIN EJ, Baden LR, Drazen JM, Taichman DB, et al
    Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
    N Engl J Med. 2021;384:e89.

    Nat Med

  43. SCHMIDT H, Weintraub R, Williams MA, Miller K, et al
    Equitable allocation of COVID-19 vaccines in the United States.
    Nat Med. 2021 May 18. pii: 10.1038/s41591-021-01379.
    PubMed         Abstract available

  44. WARD BJ, Gobeil P, Seguin A, Atkins J, et al
    Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19.
    Nat Med. 2021 May 18. pii: 10.1038/s41591-021-01370.
    PubMed         Abstract available

    PLoS One

  45. GENTILE A, Giglio N, Lucion MF, Martinez AC, et al
    Impact of varicella vaccine on nosocomial outbreaks and management of post exposure prophylaxis following in a paediatric hospital.
    PLoS One. 2021;16:e0251496.
    PubMed         Abstract available

  46. ELIZONDO-ALZOLA U, G Carrasco M, Pinos L, Picchio CA, et al
    Vaccine hesitancy among paediatric nurses: Prevalence and associated factors.
    PLoS One. 2021;16:e0251735.
    PubMed         Abstract available

  47. LEVINE G, Salifu A, Mohammed I, Fink G, et al
    Mobile nudges and financial incentives to improve coverage of timely neonatal vaccination in rural areas (GEVaP trial): A 3-armed cluster randomized controlled trial in Northern Ghana.
    PLoS One. 2021;16:e0247485.
    PubMed         Abstract available

  48. ATUHAIRE DK, Muleya W, Mbao V, Niyongabo J, et al
    Molecular characterization and population genetics of Theileria parva in Burundi's unvaccinated cattle: Towards the introduction of East Coast fever vaccine.
    PLoS One. 2021;16:e0251500.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  49. CHUMAKOV K, Avidan MS, Benn CS, Bertozzi SM, et al
    Old vaccines for new infections: Exploiting innate immunity to control COVID-19 and prevent future pandemics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


  50. BALICER RD, Ohana R
    Israel's COVID-19 endgame.
    Science. 2021;372:663.


  51. KRAIGSLEY AM, Moore KA, Bolster A, Peters M, et al
    Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00502.
    PubMed         Abstract available

  52. CHILENGI R, Mwila-Kazimbaya K, Chirwa M, Sukwa N, et al
    Immunogenicity and safety of two monovalent rotavirus vaccine, ROTAVAC(R) and ROTAVAC 5D(R) in Zambian infants.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00542.
    PubMed         Abstract available

  53. GLENN BA, Nonzee NJ, Tieu L, Pedone B, et al
    Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00454.
    PubMed         Abstract available

  54. CUTTS FT, Danovaro-Holliday MC, Rhoda DA
    Challenges in measuring supplemental immunization activity coverage among measles zero-dose children.
    Vaccine. 2021;39:1359-1363.

  55. WANG Y, Huang C, Tang J, Liu G, et al
    Salmonella Pullorum spiC mutant is a desirable LASV candidate with proper virulence, high immune protection and easy-to-use oral administration.
    Vaccine. 2021;39:1383-1391.
    PubMed         Abstract available

  56. BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
    A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
    Vaccine. 2021;39:1248-1256.
    PubMed         Abstract available

  57. NICACIO AAMF, Peracchi OAB, Yamada J, Fraga MM, et al
    Tdap booster to adolescents with juvenile idiopathic arthritis on and off anti-TNF agents is safe and immunogenic.
    Vaccine. 2021;39:1165-1172.
    PubMed         Abstract available

  58. HAI NM, Dung ND, Pho DC, Son VT, et al
    Immunogenicity, safety and reactogenicity of ROTAVAC(R) in healthy infants aged 6-8 weeks in Vietnam.
    Vaccine. 2021;39:1140-1147.
    PubMed         Abstract available

  59. DUDLEY MZ, Taitel MS, Smith-Ray R, Singh T, et al
    Effect of educational and financial incentive-based interventions on immunization attitudes, beliefs, intentions and receipt among close contacts of pregnant women.
    Vaccine. 2021;39:961-967.
    PubMed         Abstract available

  60. ARREDONDO JL, Villagomez Martinez SM, Concepcion Morales M, Meyer S, et al
    Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00546.
    PubMed         Abstract available

  61. UWABOR E, Chau V, Romanin C, Loh LC, et al
    Digital tools for vaccine reporting: A perspective from the province of Ontario.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00558.

  62. FUKUDA M, Nakamura J, Ito S, Kawazoe K, et al
    Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00561.
    PubMed         Abstract available

  63. NAKAHASHI-OUCHIDA R, Uchida Y, Yuki Y, Katakai Y, et al
    A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00552.
    PubMed         Abstract available

  64. CHAN YW, Wong ML, Kwok FY, Au AK, et al
    The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00541.
    PubMed         Abstract available

  65. LONGCHAMPS C, Ducarroz S, Crouzet L, Vignier N, et al
    COVID-19 vaccine hesitancy among persons living in homeless shelters in France.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00563.
    PubMed         Abstract available

  66. WELSH KJ, Baumblatt J, Chege W, Goud R, et al
    Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Vaccine. 2021 Apr 30. pii: S0264-410X(21)00524.
    PubMed         Abstract available

  67. MCGIRR A, Bourgoin T, Wortzman M, Millson B, et al
    An early look at the second dose completion of the recombinant zoster vaccine in Canadian adults: A retrospective database study.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00523.
    PubMed         Abstract available

  68. AWAD AM, Ntoso A, Connaire JJ, Hernandez GT, et al
    An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B(R)) in adults receiving hemodialysis.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00554.
    PubMed         Abstract available

  69. CHUNG JR, Flannery B, Kim SS, Gaglani M, et al
    Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00555.
    PubMed         Abstract available

  70. WANG J, Jiang L, Zhang C, He W, et al
    The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00560.
    PubMed         Abstract available

  71. LIU Y, Xiong Y, Liang Y, Deng X, et al
    Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: A 4-year prospective study.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00559.
    PubMed         Abstract available

  72. KALKOWSKA DA, Pallansch MA, Wassilak SGF, Cochi SL, et al
    Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00543.
    PubMed         Abstract available

  73. GROENEWEG L, Loeffen YGT, Versluys AB, Wolfs TFW, et al
    Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00508.
    PubMed         Abstract available

  74. KIM TH, Choi JH, Park SH, Yoo JH, et al
    Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged >/= 65 years.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00551.
    PubMed         Abstract available

  75. HAN B, Liu W, Du J, Liu H, et al
    Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00540.
    PubMed         Abstract available

    Virus Res

  76. CARNEIRO DC, Sousa JD, Monteiro-Cunha JP
    The COVID-19 Vaccine Development: A Pandemic Paradigm.
    Virus Res. 2021 May 17:198454. doi: 10.1016/j.virusres.2021.198454.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.